ArticleScientific reports2017

Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.

Hadley Mouhsine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.